{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:23:54Z","timestamp":1773833034159,"version":"3.50.1"},"reference-count":16,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Emerging Drugs"],"published-print":{"date-parts":[[2023,7,3]]},"DOI":"10.1080\/14728214.2023.2239151","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T14:08:59Z","timestamp":1689775739000},"page":"145-147","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Status of current trials and potential future trials with sparsentan"],"prefix":"10.1080","volume":"28","author":[{"given":"Howard","family":"Trachtman","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radko","family":"Komers","sequence":"additional","affiliation":[{"name":"Travere Therapeutics, Inc. San Diego, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jula","family":"Inrig","sequence":"additional","affiliation":[{"name":"Travere Therapeutics, Inc. San Diego, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,7,23]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00425.2015"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.933670"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.6087"},{"key":"e_1_3_3_5_1","volume-title":"Sparsentan improves glomerular endothelial and podocyte functions and augments protective tissue repair in a mouse model of focal segmental glomerulosclerosis (FSGS)","author":"Gyarmati G","year":"2022","unstructured":"Gyarmati G, Deepak S, Shroff U, et al. Sparsentan improves glomerular endothelial and podocyte functions and augments protective tissue repair in a mouse model of focal segmental glomerulosclerosis (FSGS). Orlando FL: ASN; 2022 Nov 3-6."},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa142.P0348"},{"key":"e_1_3_3_7_1","first-page":"PO1454","article-title":"The dual endothelin angiotensin receptor antagonist (deara) sparsentan protects from glomerular hypercellularity and associated immune\/inflammatory gene-network-activity in a model of iga nephropathy (Igan)","author":"Reily C","year":"2021","unstructured":"Reily C, Moldoveanu Z, Pramparo T, et al. The dual endothelin angiotensin receptor antagonist (deara) sparsentan protects from glomerular hypercellularity and associated immune\/inflammatory gene-network-activity in a model of iga nephropathy (Igan). ASN Kidney Week. 2021;PO1454. U.S.A.","journal-title":"ASN Kidney Week"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.04.024"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.04.013"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.05.013"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000135"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.02.1086"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00569-X"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2019.12.017"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04780517"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.848389"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-022-01542-3"}],"container-title":["Expert Opinion on Emerging Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728214.2023.2239151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T07:18:05Z","timestamp":1697095085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728214.2023.2239151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7,3]]}},"alternative-id":["10.1080\/14728214.2023.2239151"],"URL":"https:\/\/doi.org\/10.1080\/14728214.2023.2239151","relation":{},"ISSN":["1472-8214","1744-7623"],"issn-type":[{"value":"1472-8214","type":"print"},{"value":"1744-7623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-05-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}